Have you considered using naltrexone or other medications to curb your alcohol cravings?
As alcohol use disorder is technically a thinking problem, most of us are too afraid to discuss our symptoms with a doctor. We worry about being forced into a treatment program or denied medications due to our drinking.
And the more we try and fail to change on our own, the more shame and fear we feel…which increases your stress and perpetuates the cycle of overdrinking.
It feels like there is a ticking time bomb threatening to ruin our health, marriage and family dynamics. The guilt is overwhelming. Yet we have no idea what to do.
You already know there is no magic pill. However, there are medications that can help. But how are you supposed to get it if you don’t have a doctor you can trust?
Dr. Joshua Lee, MD specializes in medication-assisted treatment of alcohol use disorder. He is passionate about making evidence-based treatments accessible to those seeking to drink less or achieve sobriety. He is the Chief Clinical Advisor at Oar Health, a telemedicine platform that provides convenient and private access to naltrexone for anyone suffering with alcohol use disorder. In this episode, you’ll learn:
How naltrexone effects the brain to reduce alcohol cravings
The difference between the Sinclair Method and other naltrexone therapies
Success rates for naltrexone…and what to expect if you decide to try it
How to access naltrexone without if you don’t want to see your family doctor or file for insurance
Click here to BOOK A DISCOVERY CALL WITH COLLEEN Are you looking for a mindful drinking coach instead of a sobriety program? I can help you reduce your drinking by 80 percent within a month so you don't have to quit. Walk away with clarity about why you're struggling and what tools you need to achieve your goals.
Dr. Joshua Lee, MD is a highly accomplished clinician and researcher specializing in medication-assisted treatment of alcohol and opioid use disorders. Josh is passionate about making evidence-based treatment accessible to those seeking to drink less or achieve sobriety. His extensive experience includes conducting clinical trials on naltrexone and buprenorphine in primary care, criminal justice, and community settings. He also treats patients struggling with addiction as a primary care physician. Josh is a Professor of Population Health and Medicine at NYU Grossman School of Medicine, directs the ACGME-accredited Addiction Medicine Fellowship, and leads research initiatives focused on justice and community outcomes. He is also Chief Clinical Advisor at Oar Health, a telemedicine platform that makes medication-assisted treatment for alcohol use disorder convenient and private. http://www.oarhealth.com/podcast